作者投稿
专家审稿
编辑办公
邮件订阅
RSS
Diagnostic Value of Magnetic Resonance Imaging for Preoperative Staging of Endometrial Carcinoma
-
摘要:
近年来, 子宫内膜癌已成为发达国家女性生殖系统最常见的恶性肿瘤。肿瘤分期是影响子宫内膜癌治疗方式及预后的重要因素, 术前准确分期有助于识别高风险子宫内膜癌患者并制定最佳治疗方案。磁共振成像因其软组织分辨率高, 多序列、多参数成像等优势, 已成为子宫内膜癌术前分期最佳非侵入性检查方法。本文就磁共振成像在子宫内膜癌术前分期中的应用及研究进展予以综述。
Abstract:Endometrial carcinoma is the most common gynecological malignancy in developed countries and the incidence is rising in China. The stage of the endometrial carcinoma at diagnosis plays an important role in treatment planning, and is correlated with prognosis. Accurate preoperative staging of the tumor is helpful for risk stratification before surgery, which is crucial for optimal personalized management and subsequent follow-up regiments. Magnetic resonance imaging (MRI) has long been established as the most accurate noninvasive imaging modality for staging of endometrial carcinomas. And functional MRI techniques, providing more detailed characterization of tumors-vascularity, cellilarity and metabolism, are currently being intensively investigated all round the world. This review discusses the value of MRI in endometrial carcinoma.
-
Key words:
- endometrial carcinoma /
- magnetic resonance imaging /
- preoperative staging
-
[1] Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017[J]. CA Cancer J Clin, 2017, 67:7-30. doi: 10.3322/caac.21387 [2] 魏丽惠.重视子宫内膜癌的筛查[J].中华妇产科杂志, 2013, 48:881-883. doi: 10.3760/cma.j.issn.0529-567x.2013.12.001 [3] Werner HM, Trovik J, Marcickiewicz J, et al. Revision of FIGO surgical staging in 2009 for endometrial cancer validates to improve risk stratification[J]. Gynecol Oncol, 2012, 125:103-108. doi: 10.1016/j.ygyno.2011.11.008 [4] Colombo N, Creutzberg C, Amant F, et al. ESMO-ESGO-ESTRO consensus conference on endometrial cancer:diagnosis, treatment and follow-up[J]. Int J Gynecol Cancer, 2016, 26:2-30. doi: 10.1097/IGC.0000000000000609 [5] Frost JA, Webster KE, Bryant A, et al. Lymphadenectomy for the management of endometrial cancer[J]. Cochrane Database Syst Rev, 2015, 21:CD007585. doi: 10.1002/14651858.CD007585.pub2 [6] Zahl EA, Ducie J, Ali N, et al. Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion[J]. Gynecol Oncol, 2016, 140:394-399. doi: 10.1016/j.ygyno.2015.12.028 [7] Emlik D, Kiresi D, Ozdemir S, et al. Preoperative assessment of myometrial and cervical invasion in endometrial carcinoma:comparison of multi-section dynamic MR imaging using a three dimensional FLASH technique and T2-weighted MR imaging[J]. J Med Imaging Radiat Oncol, 2010, 54:202-210. doi: 10.1111/j.1754-9485.2010.02160.x [8] Koplay M, Dogan NU, Erdogan H, et al. Diagnostic efficacy of diffusion-weighted MRI for pre-operative assessment of myometrial and cervical invasion and pelvic lymph node metastasis in endometrial carcinoma[J]. J Med Imaging Radiat Oncol, 2014, 58:538-546, 648. doi: 10.1111/1754-9485.12209 [9] Lin G, Ng KK, Chang CJ, et al. Myometrial invasion in endometrial cancer:diagnostic accuracy of diffusion-weighted 3.0-T MR imaging-initial experience[J]. Radiology, 2009, 250:784-792. doi: 10.1148/radiol.2503080874 [10] Husby JA, Salvesen OO, Magnussen IJ, et al. Tumour apparent diffusion coefficient is associated with depth of myometrial invasion and is negatively correlated to tumour volume in endometrial carcinomas[J]. Clin Radiol, 2015, 70:487-494. doi: 10.1016/j.crad.2014.12.016 [11] Cao K, Gao M, Sun YS, et al. Apparent diffusion coefficient of diffusion weighted MRI in endometrial carcinoma-relationship with local invasiveness[J]. Eur J Radiol, 2012, 81:1926-1930. doi: 10.1016/j.ejrad.2011.04.019 [12] Itatani R, Namimoto T, Yoshimura A, et al. Clinical utility of the normalized apparent diffusion coefficient for preoperative evaluation of the aggressiveness of prostate cancer[J]. Jpn J Radiol, 2014, 32:685-691. doi: 10.1007/s11604-014-0367-0 [13] Lin G, Huang YT, Chao A, et al. Endometrial cancer with cervical stromal invasion:diagnostic accuracy of diffusion-weighted and dynamic contrast enhanced MR imaging at 3T[J]. Eur Radiol, 2017, 27:1867-1876. doi: 10.1007/s00330-016-4583-0 [14] Nakai G, Matsuki M, Inada Y, et al. Detection and evaluation of pelvic lymph nodes in patients with gynecologic malignancies using body diffusion-weighted magnetic resonance imaging[J]. J Comput Assist Tomogr, 2008, 32:764-768. doi: 10.1097/RCT.0b013e318153fd43 [15] Roy C, Bierry G, Matau A, et al. Value of diffusion-weighted imaging to detect small malignant pelvic lymph nodes at 3 T[J]. Eur Radiol, 2010, 20:1803-1811. doi: 10.1007/s00330-010-1736-4 [16] Lin G, Ho KC, Wang JJ, et al. Detection of lymph node metastasis in cervical and uterine cancers by diffusion-weighted magnetic resonance imaging at 3T[J]. J Magn Reson Imaging, 2008, 28:128-135. doi: 10.1002/jmri.21412 [17] Rechichi G, Galimberti S, Oriani M, et al. ADC maps in the prediction of pelvic lymph nodal metastatic regions in endometrial cancer[J]. Eur Radiol, 2013, 23:65-74. doi: 10.1007/s00330-012-2575-2 [18] Park SB, Moon MH, Sung CK, et al. Dynamic contrast-enhanced MR imaging of endometrial cancer:optimizing the imaging delay for tumour-myometrium contrast[J]. Eur Radiol, 2014, 24:2795-2799. doi: 10.1007/s00330-014-3327-2 [19] Fujii S, Kido A, Baba T, et al. Subendometrial enhancement and peritumoral enhancement for assessing endometrial cancer on dynamic contrast enhanced MR imaging[J]. Eur J Radiol, 2015, 84:581-589. doi: 10.1016/j.ejrad.2015.01.004 [20] Ippolito D, Cadonici A, Bonaffini PA, et al. Semiquantitative perfusion combined with diffusion-weighted MR imaging in pre-operative evaluation of endometrial carcinoma:results in a group of 57 patients[J]. Magn Reson Imaging, 2014, 32:464-472. doi: 10.1016/j.mri.2014.01.009 [21] Haldorsen IS, Gruner R, Husby JA, et al. Dynamic contrast-enhanced MRI in endometrial carcinoma identifies patients at increased risk of recurrence[J]. Eur Radiol, 2013, 23:2916-2925. doi: 10.1007/s00330-013-2901-3 [22] Teng F, Zhang YF, Wang YM, et al. Contrast-enhanced MRI in preoperative assessment of myometrial and cervical invasion, and lymph node metastasis:diagnostic value and error analysis in endometrial carcinoma[J]. Acta Obstet Gynecol Scand. 2015, 94:266-273. doi: 10.1111/aogs.12570 [23] Nougaret S, Reinhold C, Alsharif SS, et al. Endometrial cancer:combined MR volumetry and diffusion-weighted imaging for assessment of myometrial and lymphovascular invasion and tumor grade[J]. Radiology, 2015, 276:797-808. doi: 10.1148/radiol.15141212 [24] Sala E, Crawford R, Senior E, et al. Added value of dynamic contrast-enhanced magnetic resonance imaging in predicting advanced stage disease in patients with endometrial carcinoma[J]. Int J Gynecol Cancer, 2009, 19:141-146. doi: 10.1111/IGC.0b013e3181995fd9 [25] Andreano A, Rechichi G, Rebora P, et al. MR diffusion imaging for preoperative staging of myometrial invasion in patients with endometrial cancer:a systematic review and meta-analysis[J]. Eur Radiol, 2014, 24:1327-1338. doi: 10.1007/s00330-014-3139-4 [26] He H, Bhosale P, Wei W, et al. MRI is highly specific in determining primary cervical versus endometrial cancer when biopsy results are inconclusive[J]. Clin Radiol, 2013, 68:1107-1113. doi: 10.1016/j.crad.2013.05.095 [27] Agrawal G, Riherd JM, Busse RF, et al. Evaluation of uterine anomalies:3D FRFSE cube versus standard 2D FRFSE[J]. AJR Am J Roentgenol, 2009, 193:W558-W562. doi: 10.2214/AJR.09.2716 [28] Hori M, Kim T, Onishi H, et al. Uterine tumors:comparison of 3D versus 2D T2-weighted turbo spin-echo MR imaging at 3.0 T-initial experience[J]. Radiology, 2011, 258:154-163. doi: 10.1148/radiol.10100866 [29] Ytre-Hauge S, Husby JA, Magnussen IJ, et al. Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomas[J]. Int J Gynecol Cancer, 2015, 25:459-466. doi: 10.1097/IGC.0000000000000367 -
点击查看大图
计量
- 文章访问数: 244
- HTML全文浏览量: 53
- PDF下载量: 5
- 被引次数: 0
下载:
